Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25 TTM Selling/general/admin expenses 3.31 M3.37 M3.45 M3.46 M 13.6 M Research & development ———— — Operating income 9.77 M10.33 M10.1 M-26.73 M 3.47 M Non-Operating Income, Total 222 K290 K231 K-22.46 M -21.71 M Interest expense, net of interest capitalized 5.57 M5.63 M5.46 M5.15 M 21.81 M Non-Operating Income, excl. Interest Expenses -5.35 M-5.34 M-5.23 M-27.61 M -43.52 M Unusual income/expense ———— — Pretax income 1.55 M1.4 M1.74 M-10.52 M -5.83 M Equity in earnings ———— — Taxes 322 K296 K363 K-2.47 M -1.49 M Non-controlling/minority interest ———— — After tax other income/expense ———— — Net income before discontinued operations 1.23 M1.1 M1.38 M-8.04 M -4.34 M Discontinued operations ———— — Net income 1.23 M1.1 M1.38 M-8.04 M -4.34 M Dilution adjustment ———— — Preferred dividends ———— — Diluted net income available to common stockholders 1.23 M1.1 M1.38 M-8.04 M -4.34 M Basic earnings per share (Basic EPS) 0.060.050.07-0.39 -0.21 Diluted earnings per share (Diluted EPS) 0.060.050.07-0.39 -0.21 Average basic shares outstanding 20.98 M20.95 M20.76 M20.84 M — Diluted shares outstanding 20.98 M20.95 M20.76 M20.84 M — EBITDA 4.2 M4.37 M4.58 M-31.76 M -18.62 M EBIT 4.16 M4.35 M4.58 M-31.88 M -18.79 M Cost of revenue 225 K260 K451 K1.48 M 2.42 M Other cost of goods sold 225 K260 K351 K324 K 1.16 M Depreciation & amortization (cash flow) 43 K42 K42 K113 K 240 K